Received Nov 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
No additional AE reported; a doctor is requesting the patient be vaccinated with GARDASIL 9 and reports the patient is currently being treated for Cervical Cancer; This spontaneous report was received from a pharmacist and refers to a 70-decade-old female patient. The patient's medical history was not reported. The patient's concurrent conditions included cervical cancer. Concomitant therapies were not reported. On an unknown date, a doctor was requesting the patient be vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) for prophylaxis. It was reported that the patient was being treated for cervical cancer. It was confirmed the patient had not been administered the Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9). Pharmacist had inquired if it would be ok to give this patient Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) and she was advised it would be off label use and we could not recommend use outside of label. No further details were known or provided. No additional adverse event (AE) (no adverse event). Lot number is being requested and will be provided if available.
Cervical cancer